Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, October 23, 2015

6 major pharmaceutical companies join $100M Dementia Discovery Fund

If we had any leaders at all in stroke news like this would occur for stroke. But we have shit for leaders, not willing to try any BHAGs (Big Hairy Audacious Goals) at all. I blame the boards of directors for not setting goals like that for the presidents and choosing presidents who don't have an innovative thought in their brain.



Six pharmaceutical companies from around the world have signed on to be part of the $100 million Dementia Discovery Fund to help develop treatments than may slow or reverse dementia by 2025. Johnson & Johnson, Biogen, Lilly, GlaxoSmithKline, Takeda and Pfizer are the first drug companies to join the effort, but others will be invited in upcoming funding rounds. The fund is being managed by SV Life Sciences. The Telegraph (London) (tiered subscription model) (10/21)

There are over 9.9 million new cases of dementia each year worldwide,  compared to 15 million strokes a year worldwide and stroke has nothing in attention or visibility.

No comments:

Post a Comment